Hester Biosciences has informed that as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has arranged earnings conference call on Saturday, 30.01.2021 at 2:00 pm to discuss the Standalone and Consolidated Unaudited Financial Results for the quarter and nine months ended on 31.12.2020, as attached.
The above information is a part of company’s filings submitted to BSE.